{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:57:34Z","timestamp":1776355054552,"version":"3.51.2"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.1001\/jamaoncol.2025.6364","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:30:24Z","timestamp":1770309024000},"page":"422","source":"Crossref","is-referenced-by-count":0,"title":["Prostate-Specific Membrane Antigen PET-Guided Salvage Radiotherapy\u2014Precision or Prematurity?\u2014Reply"],"prefix":"10.1001","volume":"12","author":[{"given":"Colin","family":"Belliveau","sequence":"first","affiliation":[{"name":"Radiation Oncology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[{"name":"Urology, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CHUM), Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"M\u00e9nard","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CRCHUM), Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"12","key":"clr250028r1","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1001\/jamaoncol.2025.3746","article-title":"Prostate-specific membrane antigen PET-guided intensification of salvage radiotherapy after radical prostatectomy: a phase 2 randomized clinical trial.","volume":"11","author":"Belliveau","year":"2025","journal-title":"JAMA Oncol"},{"issue":"10","key":"clr250028r2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S1470-2045(20)30456-3","article-title":"Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03\/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.","volume":"21","author":"Kneebone","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"clr250028r3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy.","volume":"211","author":"Morgan","year":"2024","journal-title":"J Urol"},{"issue":"10260","key":"clr250028r4","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0140-6736(20)31553-1","article-title":"Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.","volume":"396","author":"Parker","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"clr250028r5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12885-022-09283-z","article-title":"PSMA PET\/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial.","volume":"22","author":"M\u00e9nard","year":"2022","journal-title":"BMC Cancer"},{"issue":"10338","key":"clr250028r6","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2844750\/jamaoncology_belliveau_2026_lr_250028_1775759228.25646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:00:47Z","timestamp":1776351647000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2844750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2025.6364","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}